Sort
64,565 grants matching “drug discovery”
Development of a multi-omic clinical decision platform to guide personalized therapy
$525,071Samir Parekh · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · CA
Development of Nucleic Acid Platform for Targeting DNA
$525,000Danith H Ly · Carnegie Mellon University · · FY2010 · MPS
Framework to Accelerate Substance Use Disorder Genetic Studies through Customizable, EHR-Based Precision Phenotyping
$525,000Alvin Dean Jeffery · Vanderbilt University Medical Center · DP1 · FY2025 · DA
CAREER: Development of Force-Activated Materials for the Release of Small Organic Molecules
$525,000Andrew J Boydston · University Of Washington · · FY2015 · MPS
High-Throughput Platform for Identifying Stem Cell Toxicity
$524,983Jonathan S. Dordick · Rensselaer Polytechnic Institute · R01 · FY2012 · ES
Depot formulation of a D-peptide HIV entry inhibitor
$524,908Alan L Mueller · Navigen, Inc. · R56 · FY2016 · AI
Development of NMUR2 Antagonists as Novel Analgesics
$524,835Neil Cutshall · Omeros Corporation · R44 · FY2012 · DA
Engineering the Vocal Fold Extracellular Matrix
$524,805Susan L Thibeault · University Of Wisconsin-Madison · R01 · FY2014 · DC
JHU- Optimal regimen development on a Ribosome inhibitor backbone.
$524,782Eric L Nuermberger · Global Alliance For Tb Drug Development · U19 · FY2019 · AI
Targeting HER2-low breast cancer with 17p loss
$524,740Xiongbin Lu · Indiana University Indianapolis · R01 · FY2023 · CA
Targeting HER2-low breast cancer with 17p loss
$524,740Xiongbin Lu · Indiana University Indianapolis · R01 · FY2022 · CA
Data and analysis ecosystem for eukaryotic pathogen targeted sequencing
$524,724Bryan R Greenhouse · University Of California, San Francisco · U01 · FY2024 · AI
Multiscale Modeling for Treatment Discovery in Duchenne Muscular Dystrophy
$524,715Silvia Salinas Blemker · University Of Virginia · U01 · FY2017 · AR
Novel antimicrobial agents to overcome antibiotic resistant Pseudomonas and MRSA respiratory infection
$524,705Yuanpu Peter Di · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · AI
Discovery of Drugs, Targets, and Target Strategies for Immunotherapy of CLL
$524,636Christoph Rader · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Gene Networks Essential to Colon Cancer Phenotype
$524,632Hartmut Land · University Of Rochester · R01 · FY2011 · CA
Training program in cancer pharmacology
$524,571Ian Alexander Blair · University Of Pennsylvania · R25 · FY2009 · CA
Developing Selective EphA2 Inhibitors for the treatment of Cancer
$524,549Nathanael Schiander Gray · Dana-Farber Cancer Inst · R01 · FY2015 · CA
Developing Selective EphA2 Inhibitors for the treatment of Cancer
$524,549Nathanael Schiander Gray · Dana-Farber Cancer Inst · R01 · FY2013 · CA
The Cellular Modeling Core for MARMO-AD
$524,539Amantha Thathiah · University Of Pittsburgh At Pittsburgh · U19 · FY2025 · AG
Translational Studies on Early-life Stress and Vulnerability to Alcohol Addiction
$524,518Jeffrey L. Weiner · Wake Forest University Health Sciences · P01 · FY2013 · AA
Development of Pre-Erythrocytic Malaria Vaccines
$524,485Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Development of Pre-Erythrocytic Malaria Vaccines
$524,485Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Core B
$524,455Bjorn E Oskarsson · Mayo Clinic Jacksonville · P01 · FY2021 · NS
New Non-Nuceleotide Reverse Transcriptase Inhibitors for Drug Resistant HIV Strains
$524,446Chin-Ho Chen · Duke University · R01 · FY2021 · AI